- Home
- PGY vs INVA Comparison
PGY vs INVA Comparison
Compare PGY & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PGY | INVA |
|---|---|---|
| Founded | 2016 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | PGY | INVA |
|---|---|---|
| Price | $21.85 | $19.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $39.43 | $36.80 |
| AVG Volume (30 Days) | ★ 3.0M | 638.5K |
| Earning Date | 02-09-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.96 |
| EPS | N/A | ★ 1.52 |
| Revenue | ★ $1,245,946,000.00 | $388,521,000.00 |
| Revenue This Year | $28.75 | $13.23 |
| Revenue Next Year | $17.23 | $8.58 |
| P/E Ratio | ★ N/A | $12.85 |
| Revenue Growth | ★ 28.33 | 10.14 |
| 52 Week Low | $8.50 | $16.52 |
| 52 Week High | $44.99 | $22.76 |
Technical Indicators
Market Signals| Indicator | PGY | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 43.84 | 48.50 |
| Support Level | $20.62 | $19.29 |
| Resistance Level | $26.80 | $19.80 |
| Average True Range (ATR) | 1.41 | 0.50 |
| MACD | -0.20 | 0.03 |
| Stochastic Oscillator | 20.23 | 60.98 |
Price Performance
Historical ComparisonAbout PGY Pagaya Technologies Ltd.
Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.